Long-Term Disabilities of Survivors of Out-of-Hospital Cardiac Arrest: The Hanox Study.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
02 2021
Historique:
received: 01 03 2020
revised: 03 07 2020
accepted: 10 07 2020
pubmed: 24 7 2020
medline: 14 9 2021
entrez: 24 7 2020
Statut: ppublish

Résumé

Long-term outcomes of awakened survivors of out-of-hospital cardiac arrest (OHCA) are poorly known. What are the month (M) 18 outcomes of survivors of out-of-hospital cardiac arrest (OHCA) who awakened during the first 2 weeks' post-OHCA and their poor-outcome risk factors? All OHCA survivors with a Glasgow Coma Scale score ≥12 during the first 2 weeks' post-OHCA were enrolled in six ICUs and followed up at M3, M6, M12, and M18. The primary outcome measure was Glasgow Outcome Scale-Extended (GOS-E) score at M18. Secondary outcome measures included evaluation at M18 of neurologic, behavioral, and cognitive disabilities; health-related quality of life (HR-QOL), anxiety and depression; and poor-outcome risk factors (GOS-E score ≤ 6). Among the 139 included patients, 98 were assessable for the primary outcome measure. At M18, 64 (65%) had full recovery or minor disabilities (GOS-E score > 6), 18 (18%) had moderate disabilities but were autonomous for daily-life activities (GOS-E score = 6), 12 (12%) had poor autonomy (GOS-E score < 6 but > 1), and four had died. Percentages of patients with GOS-E scores > 6 increased significantly over the 18-month study period. At M18, no patients had major neurologic disabilities, 20% had cognitive disabilities, 32% had anxiety symptoms, 25% had depression symptoms, and their HR-QOL was impaired compared with a sex- and age-matched population. Low-flow time, Sequential Organ Failure Assessment score at admission, coma duration > 3 days after cardiac arrest, and mechanical ventilation on days 3 and 7 were associated with poor functional outcome. Among patients who awoke (Glasgow Coma Scale score ≥12) in the 14 days following OHCA, 35% had moderate to severe disabilities or had died at M18. Interestingly, patients improved until M18 post-OHCA. Risk factors associated with poor functional outcome were low-flow time, clinical severity at ICU admission, prolonged coma duration, and mechanical ventilation. ClinicalTrials.gov; No.: NCT02292147; URL: www.clinicaltrials.gov.

Sections du résumé

BACKGROUND
Long-term outcomes of awakened survivors of out-of-hospital cardiac arrest (OHCA) are poorly known.
RESEARCH QUESTION
What are the month (M) 18 outcomes of survivors of out-of-hospital cardiac arrest (OHCA) who awakened during the first 2 weeks' post-OHCA and their poor-outcome risk factors?
STUDY DESIGN AND METHODS
All OHCA survivors with a Glasgow Coma Scale score ≥12 during the first 2 weeks' post-OHCA were enrolled in six ICUs and followed up at M3, M6, M12, and M18. The primary outcome measure was Glasgow Outcome Scale-Extended (GOS-E) score at M18. Secondary outcome measures included evaluation at M18 of neurologic, behavioral, and cognitive disabilities; health-related quality of life (HR-QOL), anxiety and depression; and poor-outcome risk factors (GOS-E score ≤ 6).
RESULTS
Among the 139 included patients, 98 were assessable for the primary outcome measure. At M18, 64 (65%) had full recovery or minor disabilities (GOS-E score > 6), 18 (18%) had moderate disabilities but were autonomous for daily-life activities (GOS-E score = 6), 12 (12%) had poor autonomy (GOS-E score < 6 but > 1), and four had died. Percentages of patients with GOS-E scores > 6 increased significantly over the 18-month study period. At M18, no patients had major neurologic disabilities, 20% had cognitive disabilities, 32% had anxiety symptoms, 25% had depression symptoms, and their HR-QOL was impaired compared with a sex- and age-matched population. Low-flow time, Sequential Organ Failure Assessment score at admission, coma duration > 3 days after cardiac arrest, and mechanical ventilation on days 3 and 7 were associated with poor functional outcome.
INTERPRETATION
Among patients who awoke (Glasgow Coma Scale score ≥12) in the 14 days following OHCA, 35% had moderate to severe disabilities or had died at M18. Interestingly, patients improved until M18 post-OHCA. Risk factors associated with poor functional outcome were low-flow time, clinical severity at ICU admission, prolonged coma duration, and mechanical ventilation.
CLINICAL TRIAL REGISTRATION
ClinicalTrials.gov; No.: NCT02292147; URL: www.clinicaltrials.gov.

Identifiants

pubmed: 32702410
pii: S0012-3692(20)31951-6
doi: 10.1016/j.chest.2020.07.022
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02292147']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

699-711

Investigateurs

Guillaume Hékimian (G)
Nicolas Bréchot (N)
Mathieu Schmidt (M)
Alain Combes (A)
Charles-Edouard Luyt (CE)
Alexandre Demoule (A)
Martin Dres (M)
Julien Mayaux (J)
Anne Peskine (A)
Hélène Robert (H)
Pascale Pradat-Diehl (P)
Eléonore Bayen (E)
Vincent Navarro (V)
Damien Galanaud (D)
Nathalie Marin (N)
Julien Charpentier (J)
Alain Cariou (A)
Jean-Paul Mira (JP)
Olivier Vignaud (O)
Emmanuel Guérot (E)
Jean-Luc Diehl (JL)
Jean-Yves Fagon (JY)
Nicolas Deye (N)
Bruno Mégarbane (B)
Jean-Pierre Guichard (JP)
Nathalie Kubis (N)
Alain Yelnik (A)
Romain Sonneville (R)
Lila Bouadma (L)
Jean-François Timsit (JF)
Isabelle Klein (I)
Tarek Sharshar (T)
Philippe Azouvi (P)
Robert Carlier (R)
Florence Colle (F)

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Anne Peskine (A)

Service de Médecine Physique et Réadaptation, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Alain Cariou (A)

Service de Médecine Intensive Réanimation, Hôpital Cochin, APHP, Paris et Université de Paris, Faculté de Médecine, Paris, France.

David Hajage (D)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, APHP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Département Biostatistique Santé Publique et Information Médicale, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.

Nicolas Deye (N)

Service de Médecine Intensive Réanimation, Hôpital Lariboisière, APHP, Paris, France.

Emmanuel Guérot (E)

Service de Médecine Intensive Réanimation, Hôpital Européen Georges-Pompidou, APHP, Paris, France.

Martin Dres (M)

Service de Pneumologie et Médecine Intensive Réanimation (département R3S), Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France.

Romain Sonneville (R)

Service de Médecine Intensive Réanimation, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.

Alexandre Lafourcade (A)

Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, APHP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Département Biostatistique Santé Publique et Information Médicale, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.

Vincent Navarro (V)

Sorbonne Université, ICM (Institut du Cerveau et de la Moelle Epinière), INSERM, CNRS, and Unité d'Épilepsie et d'EEG, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France.

Hélène Robert (H)

Service de Médecine Physique et Réadaptation, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Philippe Azouvi (P)

Service de Médecine Physique et Réadaptation, Hôpital Raymond-Poincaré, APHP, Garches, France.

Tarek Sharshar (T)

Service de Réanimation Neurochirurgicale, Hôpital Sainte-Anne, Paris, France.

Eleonore Bayen (E)

Service de Médecine Physique et Réadaptation, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Charles-Edouard Luyt (CE)

Sorbonne Université, INSERM, UMRS_1166-ICAN Institute of Cardiometabolism and Nutrition, and Service de Médecine Intensive Réanimation, Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France. Electronic address: charles-edouard.luyt@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH